Med-X (MXRX) Research & Development: $0.00 Mil (TTM As of Dec. 2022)


What is Med-X Research & Development?

Med-X MXRX Research & Development is $0.00 Mil as of Dec. 2022.

Research & Development is the aggregate amount of research and development expenses during the year. Med-X's Research & Development for the six months ended in Dec. 2022 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2022 was $0.00 Mil.

Med-X  (NAS:MXRX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Med-X Research & Development Related Terms

Med-X Research & Development Historical Data

* Premium members only.

The historical data trend for Med-X's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Med-X Research & Development Chart

Med-X Annual Data
Trend Dec20 Dec21 Dec22
Research & Development
0.00 0.00 0.00

Med-X Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22
Research & Development 0.00 0.00 0.00 0.00 0.00

Med-X Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Med-X (MXRX) has a Research & Development of $0.00 Mil as of Dec. 2022. Research and development expense is the total cost for research and development activities. View historical data on Med-X and its competitors.
Is Med-X's Research & Development too high?
Med-X's current Research & Development is $0.00 Mil.
How does Med-X's Research & Development compare to ?
Med-X's Research & Development of $0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Med-X and its competitors. Med-X's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med-X stock overvalued right now?
Med-X (MXRX) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Med-X (MXRX), the current Research & Development is $0.00 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Med-X Business Description

Comparable Companies
Address 8236 Remmet Avenue, Canoga Park, CA, USA, 91304
Med-X Inc is engaged in the business of product development, distribution, and marketing of products, which currently consist of Nature-Cide, Thermal-Aid, and Malibu Brands. Nature-Cide products include natural essential oil blends of indoor and outdoor pesticide/insecticide/repellent developed for multiple industries, including professional pest control, turf care, janitorial, hospitality, transportation, and agriculture. Thermal-Aid, Thermal-Aid Zoo, and the Thermal-Aid Headache Relief System are natural heating/cooling pain and physical therapy products for painful ailments affecting adults, children, and animals. Nature-Cide. Malibu Brands has only one product available, an all-natural essential oil pain management cream.